|
EQS-News: Endexx Corporation
/ Key word(s): Financial
LOS ANGELES, CA - Acknowledgment and Transition The Board of Directors extends its gratitude to Todd Davis for his years of dedication and leadership. Todd has played a pivotal role in Endexx's growth and success. We look forward to his continued support as he works closely with Brad and the team during this transition. Strategic Leadership and Vision The decision to transition to new leadership under Strategic Innovations First, Inc. (SIF) was driven by the Board's strategic vision to enhance operational efficiencies and expand market presence. Brad, known for his extensive experience in strategic business growth and investor relations, will bring fresh perspectives and innovative approaches to propel Endexx Corporation forward. Comprehensive Management Support In addition to Brad's leadership, SIF will bring a team of experienced consultants to support Endexx’s management. Among these consultants is Lt. Colonel Elton Johnson Jr., a highly decorated war hero and the founder of Amerivet Securities. Lt. Colonel Johnson, who holds Series 7 and 22 licenses, specializes in deep-diving financial operations and will provide invaluable expertise to strengthen Endexx’s financial strategies. Collaboration and Future Goals Brad and the team at SIF will work closely with Endexx's Board of Directors and under the feedback of shareholders, whom Brad recognizes as his true bosses. This collaboration aims to align strategic objectives, drive innovation, improve market engagement, and enhance shareholder value. One key goal is to find a full-time CEO for Endexx in the future, ensuring the company's long-term stability and growth. About Endexx Corporation Endexx Corporation develops and distributes all-natural, plant-derived wellness products and topical skincare products. Its products range from balms, creams, lotions, kinds of butter, masks, scrubs, and oils, all aimed at promoting healthy skin and grooming wellness. The science behind these products is backed by a decade of clinical research, ensuring functional formulations with ingredients for optimal absorption and skin health support. www.endexx.com HYLA, a division of Endexx, markets proprietary non-nicotine, guarana, and L-Dopa-based vape products in various flavors. The HYLA device is a first-of-its-kind non-nicotine vape product in the United States, offering up to 4,500 puffs per device. HYLA is currently distributed in 10 countries, with distribution agreements in an additional nine countries. www.tryhyla.com Forward-Looking Statements This press release contains forward-looking statements, which involve risks and uncertainties. These statements include but are not limited to, future operating results and the implementation and impact of our strategic plans. Words such as "estimate," "commit," "target," "goal," "project," "plan," "believe," "seek," "strive," "expect," "anticipate," "intend," "potential," and any similar expressions may identify forward-looking statements. Our actual results may differ materially from those expressed or implied due to various factors, many of which are beyond our control. For more information on potential risks, please refer to our amended Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on June 9, 2023. Contact Information For further information, please get in touch with Endexx Corporation at IR@endexx.com Text: 424-250-0042 or brad@solutionsnow.info
News Source: Endexx Corporation
16.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Endexx Corporation |
| United States | |
| ISIN: | US29259K1025 |
| EQS News ID: | 1947567 |
| End of News | EQS News Service |
|
|
1947567 16.07.2024 CET/CEST